Phase-I Pilot Study: Investigating objective measures of pain-processing-related nociception and subjective pain perception in an elderly cohort in the presence and absence of a standard analgesic on irritated (UVB) and non-irritated skin

This academic pilot-study – in cooperation with the School of Pharmacy of the University of Waterloo in Ontarion Canada – was completed by end July 2011. The statistical analysis of all experimental data (after online acquisition) was completed. The results confirm earlier findings with the investigated compound, but demonstrate age-related influences.
________________________________________________________________

This is normally a place for German posts only – as we are looking for German-speaking volunteers to take part in our clinical studies!

For more detailed information on our actual clinical studies and designs, please contact
HPR Dr. Schaffler GmbH

________________________________________________________________

Weitere Informationen erhalten Sie im Prüfzentrum HPR Dr. Schaffler GmbH/ Heisenbergbogen 1 (Europa Forum I) in D-85609 Aschheim-Dornach bei München unter der Telefonnummer 089-99322-0, Sprechzeiten von 10-17 Uhr.

Nur ambulante Studien, keine Hospitalisierung!

Sehen Sie auch bei anfallenden Studien unsere aktuellen Anzeigen auf http://www.probanden-service.de/probanden-gesucht.html und unter Studienteilnehmer/Probanden<Nützliche Links>

About Klaus Schaffler

Dr. med. Klaus Schaffler (MD) has been specializing in the electrophysiology and pharmacology of the human central nervous system (CNS) – as well as in the field of human experimental pain research. During this development process, HPR Dr. Schaffler GmbH has issued over 175 presentations/ publications (sharing more than 50 on pain/ analgesia) and has conducted more than 150 phase-I studies with quite different objectives.
This entry was posted in Clinical Studies. Bookmark the permalink.